Anne Audelin

Anne Audelin has extensive work experience in the field of pharmaceuticals and biotechnology. Anne started their career at Gentofte Hospital, where they worked as a Student Job from 1999 to 2004. Anne then joined Rigshospitalet as a Student Job from 2005 to 2007.

In 2007, Anne Audelin joined Statens Serum Institut as a Cand. Scient, where they conducted research on HIV and developed antiviral resistance in Denmark. Anne also established and validated a national HIV Sequence database during their Ph.D. project, which they worked on from 2008 to 2013.

Following their time at Statens Serum Institut, Anne Audelin joined Bavarian Nordic in 2013 as a Process Development Scientist. Anne worked on CMC and Tech Transfer Documentation for early phase clinical material and commercial production. Anne also led process development studies and was responsible for product specifications and justifications. Anne Audelin held this position until 2018.

From 2018 to 2022, Anne Audelin served as a Sr Scientist CMC technical lead at Bavarian Nordic. In this role, they were responsible for program planning, technical transfer of manufacturing processes, and product supply for the Bavarian Nordic COVID vaccine program. Anne collaborated with clinical and regulatory teams to define strategies and ensure the development of the program. Anne Audelin also served as a mentor and supporter for team members and project managers.

Since 2022, Anne Audelin has been working as a Manager at Bavarian Nordic, where they oversee a group of production specialists. Their main responsibilities include coordinating, prioritizing, and supporting the development of the team to ensure the best possible support to production.

Throughout their career, Anne Audelin has gained expertise in various aspects of pharmaceutical development, including production management, process development, project management, and stakeholder collaboration.

Anne Audelin has a strong education background in the field of health sciences and molecular biology. Anne earned a Doctor of Philosophy (Ph.D.) degree from Københavns Universitet - University of Copenhagen's Faculty of Health Science between 2008 and 2011. Prior to that, they obtained a Cand.Sceint degree in Molecular Biology from Roskilde University from 2001 to 2007. In addition, they pursued a Master of Public Health Science from Københavns Universitet - University of Copenhagen, specializing in Public Health Science, from 2004 to 2006. Anne also briefly attended McGill University in 1999 and 2000, although the degree they pursued is not specified. Their education journey began in 1992 at Virum Gymnasium, although the degree they obtained and the field of study are not mentioned.